FOXC1 expression status has now also been shown to be a poor prognostic indicator in multiple gastrointestinal cancers including esophageal cancer, gastric cancer, liver cancer, pancreatic cancer and colon cancer. This evidence concerns the gene FOXC1 and malignant colon neoplasm.